English | Español

Biospace
Patient Daily | Dec 9, 2025

Prasad memo prompts debate as FDA sees leadership changes and new drug data emerges
Patient Daily | Dec 9, 2025

Bristol Myers Squibb postpones Alzheimer’s psychosis drug trial results after site irregularities
Patient Daily | Dec 9, 2025

Early-stage biotech firms urged to address tariff risks in planning
Patient Daily | Dec 9, 2025

Harmony's EPX-100 reduces seizures by half in Dravet syndrome Phase III trial
Patient Daily | Dec 9, 2025

Pharma explores learning from China's R&D efficiencies amid growing licensing deals
Patient Daily | Dec 9, 2025

FDA prepares major drug approval decisions for BMS, GSK, Amgen and others
Patient Daily | Dec 9, 2025

Protego Biopharma raises $130M series B for pivotal amyloidosis drug trial
Patient Daily | Dec 9, 2025

Building next-generation biologics relies on AI integration and automation advances

Trending
+ Pharmaceuticals
Patient Daily | Mar 16, 2026

Five therapies show progress in multiple myeloma treatment landscape
+ Pharmaceuticals
Patient Daily | Mar 16, 2026

FDA advisory committee to review two AstraZeneca cancer drugs in April meeting
+ Regulatory
Patient Daily | Mar 12, 2026

Texas Medical Association announces concerns over pharmacy benefit manager consolidation
+ Pharmaceuticals
Patient Daily | Mar 16, 2026

FDA biologics director Vinay Prasad to depart in April, analysts predict impact on biotech